FindTrial
Sign In

In this study compares two different drugs Sugammadex and Neostigmine/glycopyrrolate combination to see their effect on ability of adults to breathe out air after laparoscopic cholecystectomy

Effect of sugammadex versus neostogmine/glycopyrrolate combination on peak expiratory flow rates in adult patients undergoing laparoscopic surgery - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083913
Enrollment
86
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: sugammadex: TO SEE THE EFFECT OF SUGAMMADEX ON PEAK EXPIRATORY FLOW RATES IN ADULT PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY Control Intervention1: Neostigmine+glycopyrrolate: Do

Sponsors

Dr Penna Srihitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1-3, scheduled for laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: previously diagnosed respiratory disorders, BMI more than 30 kg/m2, Uncooperative patient, patient for emergency surgery, patients allergic to sugammadex or neostigmine

Design outcomes

Primary

MeasureTime frame
To compare peak expiratory flow ratesTimepoint: 30minutes post extubation—

Secondary

MeasureTime frame
Time intervalTimepoint: Administration of reversal agent to extubation;Time to attain TOF more than 0.9Timepoint: ;Need for re intubationTimepoint: Post extubation;Incidence of PPCTimepoint: post operative;To compare global lung ultrasound scoresTimepoint: 30minutes post extubation;Time taken for modified aldrete score to reach more than 8Timepoint: Post operative;To note total duration of pneumoperitoneumTimepoint: Intraoperative—

Countries

India

Contacts

Public ContactDr Vikas Saini

PGIMER CHANDIGARH

drvsaini@gmail.com7087008119

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026